Sally Robinson

1.2k total citations
41 papers, 812 citations indexed

About

Sally Robinson is a scholar working on Small Animals, Immunology and Computational Theory and Mathematics. According to data from OpenAlex, Sally Robinson has authored 41 papers receiving a total of 812 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Small Animals, 10 papers in Immunology and 5 papers in Computational Theory and Mathematics. Recurrent topics in Sally Robinson's work include Animal testing and alternatives (22 papers), Immunotoxicology and immune responses (6 papers) and Biosimilars and Bioanalytical Methods (6 papers). Sally Robinson is often cited by papers focused on Animal testing and alternatives (22 papers), Immunotoxicology and immune responses (6 papers) and Biosimilars and Bioanalytical Methods (6 papers). Sally Robinson collaborates with scholars based in United Kingdom, United States and France. Sally Robinson's co-authors include Kathryn Chapman, Ruth Roberts, Stefan Platz, Stefan Kavanagh, Howard R. Mellor, Christopher E. Pollard, Stuart Creton, Fiona Sewell, David Mitchell and К. Ray Chaudhuri and has published in prestigious journals such as Anesthesiology, Journal of Neurology Neurosurgery & Psychiatry and Drug Discovery Today.

In The Last Decade

Sally Robinson

37 papers receiving 735 citations

Peers

Sally Robinson

IMMUN

CTM

Derek Fry United Kingdom

Kary E. Thompson United States

Nieves Martín‐Alguacil Spain

Marjan Fallah Iran

Carlos Sanabria United States

Lucia Pötsch Germany

Pierre Tachon France

Miriam Sander United States

Ross Dixon United States

John A. Labudde United States

Derek Fry United Kingdom

Sally Robinson

329 ×1.1

35 ×0.2

IMMUN

141 ×1.2

55 ×0.6

59 ×0.7

CTM

Citations per year, relative to Sally Robinson Sally Robinson (= 1×) peers Derek Fry

Countries citing papers authored by Sally Robinson

Since Specialization

Citations

This map shows the geographic impact of Sally Robinson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sally Robinson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sally Robinson more than expected).

Fields of papers citing papers by Sally Robinson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sally Robinson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sally Robinson. The network helps show where Sally Robinson may publish in the future.

Co-authorship network of co-authors of Sally Robinson

This figure shows the co-authorship network connecting the top 25 collaborators of Sally Robinson. A scholar is included among the top collaborators of Sally Robinson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sally Robinson. Sally Robinson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Robinson, Sally, et al.. (2025). Supported Decision‐Making Rights in Behaviour Support Policies. Australian Journal of Social Issues.

Sewell, Fiona, Manoj Aggarwal, Gerald Bachler, et al.. (2017). The current status of exposure-driven approaches for chemical safety assessment: A cross-sector perspective. Toxicology. 389. 109–117. 25 indexed citations

Robinson, Sally, et al.. (2016). The influence of facility and home pen design on the welfare of the laboratory-housed dog. Journal of Pharmacological and Toxicological Methods. 83. 21–29. 8 indexed citations

Sewell, Fiona, et al.. (2016). Opportunities to Apply the 3Rs in Safety Assessment Programs. ILAR Journal. 57(2). 234–245. 15 indexed citations

Dudoignon, Nicolas, et al.. (2015). Making progress and gaining momentum in global 3Rs efforts: how the European pharmaceutical industry is contributing.. PubMed. 54(2). 192–7. 9 indexed citations

Robinson, Sally, et al.. (2015). Refining dosing by oral gavage in the dog: A protocol to harmonise welfare. Journal of Pharmacological and Toxicological Methods. 72. 35–46. 11 indexed citations

Cotton, P B, et al.. (2015). Spontaneous Pathology and Routine Clinical Pathology Parameters in Aging Beagle Dogs. Veterinary Pathology. 53(2). 447–455. 6 indexed citations

Chapman, Kathryn, Simon Chivers, David Mitchell, et al.. (2014). Overcoming the barriers to the uptake of nonclinical microsampling in regulatory safety studies. Drug Discovery Today. 19(5). 528–532. 56 indexed citations

Powles‐Glover, Nicola, Sarah Kirk, Chris Wilkinson, Sally Robinson, & Jane Stewart. (2014). Assessment of toxicological effects of blood microsampling in the vehicle dosed adult rat. Regulatory Toxicology and Pharmacology. 68(3). 325–331. 26 indexed citations

10.

Guillén, Javier, Sally Robinson, Thierry Decelle, Cornelia Exner, & Martje Fentener van Vlissingen. (2014). Approaches to animal research project evaluation in Europe after implementation of Directive 2010/63/EU. Lab Animal. 44(1). 23–31. 9 indexed citations

11.

Robinson, Sally, et al.. (2014). Safe at school. 1 indexed citations

12.

Voon, Valerie, Alexandra Rizos, Nicola Mulholland, et al.. (2013). Impulse control disorders in Parkinson's disease: decreased striatal dopamine transporter levels. Journal of Neurology Neurosurgery & Psychiatry. 85(2). 148–152. 75 indexed citations

13.

Roberts, Ruth, Stefan Kavanagh, Howard R. Mellor, et al.. (2013). Reducing attrition in drug development: smart loading preclinical safety assessment. Drug Discovery Today. 19(3). 341–347. 62 indexed citations

14.

Ryan, David P., et al.. (2013). Target organ toxicities in studies conducted to support first time in man dosing: An analysis across species and therapy areas. Regulatory Toxicology and Pharmacology. 65(3). 334–343. 26 indexed citations

15.

Chapman, Kathryn, Fiona Sewell, Matthias Festag, et al.. (2013). A global pharmaceutical company initiative: An evidence-based approach to define the upper limit of body weight loss in short term toxicity studies. Regulatory Toxicology and Pharmacology. 67(1). 27–38. 46 indexed citations

16.

Wolfensohn, Sarah, Penny Hawkins, Elliot Lilley, et al.. (2012). Reducing suffering in animal models and procedures involving seizures, convulsions and epilepsy. Journal of Pharmacological and Toxicological Methods. 67(1). 9–15. 12 indexed citations

17.

Robinson, Sally, et al.. (2012). Reducing dog use in one month toxicology studies without affecting scientific quality. Toxicology Letters. 211. S180–S181.

18.

Robinson, Sally, et al.. (2011). Opportunities to minimise animal use in pharmaceutical regulatory general toxicology: A cross-company review. Regulatory Toxicology and Pharmacology. 61(2). 222–229. 43 indexed citations

19.

Seidle, Troy, Sally Robinson, Tom Holmes, et al.. (2010). Cross-Sector Review of Drivers and Available 3Rs Approaches for Acute Systemic Toxicity Testing. Toxicological Sciences. 116(2). 382–396. 36 indexed citations

20.

Robinson, Sally, Matthias Festag, Sophie Kervyn, et al.. (2007). A European pharmaceutical company initiative challenging the regulatory requirement for acute toxicity studies in pharmaceutical drug development. Regulatory Toxicology and Pharmacology. 50(3). 345–352. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact